EXC
58
11
KR
59
10
NWL
35
-4
AIG
66
4
MAS
51
-11
DLTR
44
-7
ABT
45
-3
NVDA
60
-3
IP
62
-2
LRCX
55
-6
DNB
46
-2
SLB
46
2
PLD
58
10
TJX
58
-3
BRK.B
47
2
SIG
79
-2
HUM
43
-4
UNM
70
2
KIM
51
4
FOX
50
2
EXC
58
11
KR
59
10
NWL
35
-4
AIG
66
4
MAS
51
-11
DLTR
44
-7
ABT
45
-3
NVDA
60
-3
IP
62
-2
LRCX
55
-6
DNB
46
-2
SLB
46
2
PLD
58
10
TJX
58
-3
BRK.B
47
2
SIG
79
-2
HUM
43
-4
UNM
70
2
KIM
51
4
FOX
50
2
Financhill
Back

Krystal Biotech Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
38

KRYS
Krystal Biotech

Last Price:
163.99
Seasonality Move:
17.64%
Sell
30

ALNY
Alnylam Pharmaceuticals

Last Price:
149.30
Seasonality Move:
19.79%
Sell
38
Krystal Biotech (KRYS) is a Sell

Is Krystal Biotech a Buy, Sell or Hold?

  • The current Krystal Biotech [KRYS] share price is $164.10. The Score for KRYS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • KRYS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $149.40. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRYS Stock Price Chart

What is Krystal Biotech's stock price today?

  • The Krystal Biotech share price today is $164.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $149.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

KRYS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.97 Sell
Relative Strength Index (14 RSI): 53.52 Buy
Chaikin Money Flow: 151123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (155.89 - 164.93) Buy
Bollinger Bands (100): (122.92 - 172.48) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 49.64 Sell
Chaikin Money Flow: -157058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.92 - 151.18) Buy
Bollinger Bands (100): (144.43 - 179.11) Sell

KRYS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 159.57 Buy
20-day SMA: 158.91 Buy
50-day SMA: 167.56 Sell
200-day SMA: 131.09 Buy
8-day EMA: 160.98 Buy
20-day EMA: 161.15 Buy
50-day EMA: 159.69 Buy
200-day EMA: 135.56 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 149.99 Sell
20-day SMA: 148.6 Buy
50-day SMA: 149.26 Buy
200-day SMA: 169.18 Sell
8-day EMA: 149.7 Sell
20-day EMA: 149.44 Sell
50-day EMA: 151.58 Sell
200-day EMA: 167.28 Sell

Krystal Biotech Earnings Growth & KRYS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.66 per share, an increase next quarter of $0.28 per share, an increase this year of $3.59 per share, and an increase next year of $2.08 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):